{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Increased Scrutiny of Drug Pricing – What Should Pharmaceutical Companies Know",
"url": "https://www.lexblog.com/2016/02/24/4-2/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-3MKG6BZP",
"url": "https://www.lexblog.com/lib/3MKG6BZP/"
},
"datePublished": "2016-02-24T11:00:00-05:00",
"dateModified": "2018-07-26T10:21:48-04:00",
"author": {
"@type": "Person",
"name": "Lee H. Rosebush, Nita Garg, Lindsay Holmes"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Baker & Hostetler LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Law Update",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://www.healthlawupdate.com/?p=3509",
"sourceStability": "may-move"
}